
Citibest-P 500mg/800mg Tablet
Marketer
Growmax Medicare Pvt Ltd
Salt Composition
Citicoline (500mg) + Piracetam (800mg)
Overview Citibest-P 500mg/800mg Tablet
Neuro-Mend 500mg/800mg tablets are prescribed for post-stroke recovery and cognitive enhancement. This medication safeguards brain cells from injury and facilitates their repair, finding application also in treating brain injuries. Neuro-Mend 500mg/800mg tablets can be administered with or without food, ideally at the same time daily for consistent blood levels. Follow your physician's dosage and duration instructions precisely. If a dose is missed, take it immediately upon recollection. Complete the entire treatment course, even if feeling improved, and never discontinue use abruptly without consulting your doctor; sudden cessation might exacerbate symptoms. Potential side effects, such as restlessness, abdominal discomfort, anxiety, and low blood pressure, are usually transient and self-limiting. Consult your physician if these persist or are bothersome. Maintain adequate hydration by drinking plenty of fluids to counteract potential diarrhea. Weight gain is possible; counter this with a balanced diet and regular exercise.
Uses of Citibest-P 500mg/800mg Tablet
Stroke Recovery and Rehabilitation
Major Benefits of Citibest-P 500mg/800mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Citibest-P 500mg/800mg tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Citibest-P 500mg/800mg Tablet:
- Weight gain
- Hyperactivity
- Stomach pain
- Nervousness
- Diarrhea
- Decreased blood pressure
- Uncoordinated body movements
- Dizziness
How to use Citibest-P 500mg/800mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Citibest-P 500mg/800mg tablets can be consumed with or without food, although consistent timing is recommended.
How Citibest-P 500mg/800mg Tablet works:
Combiplus-NP 500mg/800mg tablets contain citicoline and piracetam, two neuroprotective agents. Citicoline fosters neuronal health by promoting cell survival and shielding against damage. Piracetam, a GABAergic compound, safeguards brain and nervous system tissue from oxygen deprivation and modulates ion channel activity within neuronal membranes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption alongside Citibest-P 500mg/800mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Citibest-P 500mg/800mg tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Citibest-P 500mg/800mg tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Citibest-P 500mg/800mg Tablets, which can induce drowsiness and tremors. Side effects from this medication may impact your capacity to operate a vehicle.
KidneyCAUTION
Patients with kidney impairment should use 500mg/800mg Citibest-P tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Citibest-P 500mg/800mg tablets are contraindicated in individuals with severe kidney disease.
LiverSAFE IF PRESCRIBED
The use of Citibest-P 500mg/800mg tablets in patients with hepatic impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Citibest-P 500mg/800mg Tablet :
Should you forget a Citibest-P 500mg/800mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Citibest-P 500mg/800mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience (Central Nervous System) |
